IN-DATE
786824: Bard InLay Optima Ureteral Stent Kit w/Nitinol Guidewire 8F x 24cm
Sign in to add this product to your favorites!
| Price: | $85.00 per kit |
|---|---|
| Quantity: | |
| In Stock: | 1 kits |
| Expiration: | 08-2026 |
Related Items
QUICK VIEW
| 788830 - Size: 8.0F $79.00 per box of 1 Bard InLay Optima Ureteral Stent 30cm x 8F Exp: 07-2027 Units in stock: 1 box of 1 | Order Qty |
QUICK VIEW
| G15049 - Size: 8.0F $11.50 EACH Cook Zaontz Urethral Stent 8F x 12cm Exp: 07-2025 (or later) Units in stock: 27 | Order Qty |
QUICK VIEW
| G17185 - Size: 8.0F $99.00 EACH Cook Bander Ureteral Diversion Stent Set, Sof-Flex, Open-End 8.2F x 75cm Exp: 06-2027 Units in stock: 2 | Order Qty |
QUICK VIEW
| G15047 - Size: 8.0F $25.00 EACH Cook Firlit-Kluge Urethral Stent 8F x 30cm Exp: 12-2025 Units in stock: 5 | Order Qty |
QUICK VIEW
| G49921 - Size: 8.0F $45.00 EACH Cook Universa Firm Ureteral Stent & Positioner: 8F x 24cm (No Box) Exp: 09-2026 Units in stock: 1 | Order Qty |
Additional Details
BD Bard INLAY OPTIMA® URETERAL STENT
The INLAY OPTIMA® stent continues the legacy of the BARD® INLAY® stent. It has been engineered to achieve optimal patient comfort by having an ultra-smooth surface and the ability to soften at body temperature. Add to this an indwelling time of up to 365 days as well as an innovative solution to the problem of urine calcium salt accumulation and you have a product that can continue to live up to the INLAY® stent name.
Manufacturer
C.R. Bard (a part of BD - Becton, Dickinson and Company) was a global leader in the development and manufacturing of innovative medical technologies. Known for their high-quality products, Bard specialized in solutions for vascular access, urology, oncology, and surgical specialties. Their product portfolio included catheters, biopsy devices, implantable ports, and hernia repair systems, designed to enhance patient care and procedural efficiency. As part of BD, the legacy of C.R. Bard continues to drive advancements in healthcare, delivering trusted solutions that improve outcomes for patients and providers worldwide.
